[A16-08] Brivaracetam - Benefit assessment according to §35a Social Code Book V
Last updated 04.08.2016
Project no.:
A16-08
Commission:
Commission awarded on 11.02.2016 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Head and nerves
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A18-48 | Brivaracetam (epilepsy) - Benefit assessment in accordance with §35a Social Code Book V | Commission completed |
| A16-38 | Brivaracetam - Addendum to Commission A16-08 | Commission completed |
| A22-32 | Brivaracetam (epilepsy in children [aged 2 to < 4 years]) - Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2016-08-04 A G-BA decision was published.